Teladoc Health, Inc. (TDOC) Total Return CAGR:9.81%(TTM)
Over the latest trailing 12-month period, Teladoc Health, Inc. (TDOC)'s total return cagr is +9.81%. The comparable SPY value is +26.64%. Year-to-date total return is +8.29%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Teladoc Health, Inc.'s Total Return CAGR averages -31.80% over 3 years and -45.50% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Teladoc Health, Inc.'s investment performance.
TDOC Total Return CAGR Chart
Teladoc Health, Inc. (TDOC)
TDOC Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
TDOC Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 36.84 | 39.89 | +3.05 | +8.29% | +8.29% |
| 2025 | 47.84 | 36.84 | -11.00 | -22.99% | -22.99% |
| 2024 | 113.42 | 47.84 | -65.58 | -57.82% | -57.82% |
| 2023 | 124.47 | 113.42 | -11.05 | -8.88% | -8.88% |
| 2022 | 483.26 | 124.47 | -358.79 | -74.24% | -74.24% |
| 2021 | 1052.42 | 483.26 | -569.16 | -54.08% | -54.08% |
| 2020 | 440.63 | 1052.42 | +611.79 | +138.84% | +138.84% |
| 2019 | 260.89 | 440.63 | +179.74 | +68.89% | +68.89% |
| 2018 | 183.42 | 260.89 | +77.47 | +42.24% | +42.24% |
| 2017 | 86.84 | 183.42 | +96.58 | +111.21% | +111.21% |
| 2016 | 94.53 | 86.84 | -7.68 | -8.13% | -8.13% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 40 | +39.1% | -13.0% |
| Q1 2026 | 29 | -21.4% | -32.6% |
| Q4 2025 | 36 | -15.5% | -25.6% |
| Q3 2025 | 43 | -5.9% | -10.7% |
| Q2 2025 | 46 | +7.7% | -14.2% |
| Q1 2025 | 43 | -13.1% | -46.2% |
| Q4 2024 | 49 | +1.4% | -57.9% |
| Q3 2024 | 48 | -9.6% | -50.5% |
| Q2 2024 | 53 | -32.6% | -59.8% |
| Q1 2024 | 79 | -31.9% | -39.9% |
| Q4 2023 | 116 | +19.3% | -6.6% |
| Q3 2023 | 98 | -26.6% | -26.9% |
| Q2 2023 | 133 | +0.9% | -28.0% |
| Q1 2023 | 132 | +5.8% | -65.3% |
| Q4 2022 | 124 | -6.7% | -74.9% |
| Q3 2022 | 133 | -27.7% | -80.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita